Certification highlights company’s mission and focus on federated technology and best community practices around genomic data security
LONDON, UK – March 11, 2020 – Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced it has been awarded International Organization for Standardization (ISO)27001 certification, a widely recognised international standard outlining best practices for information security management systems. The successful completion of this certification underscores Lifebit’s commitment to 100% data security and compliance, exemplified in its product Lifebit CloudOS, the fully federated cloud-native genomics operating system deployed by many leading life sciences organisations.
In today’s digital age, the integrity and security of genomic data are more critical than ever. With the rapid advancements in genomic research and the increasing amount of sensitive information being generated, ensuring data privacy is a top priority. The implications of genomic data misuse can be profound, impacting not just individuals but also entire research communities and institutions.
Ensuring Genomic Data Security in Bioinformatics
Moreover, the rise of cyber threats poses continuous challenges to organizations dealing with genomic data. Cybersecurity incidents can lead to significant data breaches, exposing sensitive information and damaging an organization’s reputation. Therefore, investing in robust cybersecurity measures is crucial to prevent unauthorized access and ensure the security of genomic data.
Furthermore, educating employees about data security practices is vital in fostering a culture of security within organizations. Regular training sessions can equip staff with the knowledge to recognize potential threats, respond appropriately, and maintain compliance with security protocols. This proactive approach to education can significantly reduce the risk of human error, which is often a leading cause of data breaches.
In the context of Lifebit, the commitment to genomic data security is evident in its innovative approach to cloud technologies. The company has developed solutions that not only adhere to ISO standards but also leverage cutting-edge technology to ensure the security of genomic data across various environments. This includes partnerships with other technology providers to enhance the security framework and ensure compliance with global standards.
As genomic data continues to play a pivotal role in personalized medicine, ensuring its security becomes a collective responsibility among all stakeholders. Researchers, institutions, and technology providers must collaborate to establish frameworks and protocols that protect sensitive information while promoting innovation in genomic research.
Ultimately, Lifebit’s dedication to genomic data security is not just about meeting standards but about fostering a culture of transparency, responsibility, and innovation. By leading the way in secure genomic data management, Lifebit is helping to shape the future of genomics and its application in healthcare, paving the way for more secure and effective solutions in the field.
The future of genomic data security looks promising, with ongoing advancements in technology and regulatory frameworks. Organizations that prioritize data security not only comply with legal standards but also gain a competitive advantage in the marketplace. As trust in data handling practices grows, so too does the potential for innovation and collaboration in the field of genomics.
Moreover, the importance of secure data sharing cannot be understated in genomic research. Collaborations between institutions can lead to groundbreaking discoveries; however, these collaborations also require rigorous data governance and security measures. Lifebit’s federated data analysis methods exemplify a best practice approach, allowing for the secure sharing of genomic data while maintaining privacy and compliance.
Additionally, the use of advanced technologies such as artificial intelligence (AI) and machine learning can enhance genomic data security. These technologies can help in detecting anomalies and potential threats in real-time, enabling organizations to respond swiftly to any security concerns. By integrating AI-driven solutions, companies can create more resilient security architectures that adapt to evolving threats.
Organizations that handle genomic data must adhere to stringent regulations and best practices to protect sensitive information. For example, the Health Insurance Portability and Accountability Act (HIPAA) in the United States sets standards for the protection of health information, including genomic data. Compliance with such regulations not only helps secure data but also builds trust with clients and stakeholders.
This certification reinforces the importance of genomic data security in the technological landscape.
ISO certification provides validation by a third-party audit firm that Lifebit meets strict security and compliance requirements for data protection. ISO 27001 certification is one of the most widely recognised and internationally accepted information security standards. Attaining this award requires companies to satisfy independent auditors that their business is systematic and rigorous in its approach to managing sensitive company and customer information.
Dr Maria Chatzou Dunford, Lifebit CEO, said, “Information security is absolutely paramount in genomics, and our number one priority is protecting our clients’ and partners’ data, ensuring their ongoing success. Our ISO certification highlights this driving focus on our clients, data security, quality compliance and best community standards. In fact, we engineered Lifebit CloudOS to be the first fully federated multi party system that solidifies upon the zero-trust principle best practices to effectively minimise potential threats and data compliance breaches. ISO certification is a strong component of our unrelenting focus on security and compliance around highly sensitive genomic and other personal data.”
Genetic data privacy and compliance are ensured when federated data analysis methods are employed, which allows researchers to abstract analyses on top of secure multi-party computation systems. A federated approach allows two or more parties in a distributed system to perform secure analysis without exposing private data to risks, applying highly optimised privacy-preserving and secure computation techniques to safeguard genomic data sharing and analysis. Unlike any other genomics platform, with Lifebit CloudOS, analyses run over distributed data where the data resides rather than having to move data.
About Lifebit
Lifebit CloudOS is democratising the analysis and understanding of genomics big data to leap forward cures and enhance life. The end-to-end cloud operating system brings computation and analysis to data, wherever it resides, accelerating genomics research and delivering enriched insights in personalised medicine. Users are able to scale quickly while drastically reducing costs and speeding time to insights while harnessing the awesome power of AI – positively transformative for the scientists and researchers who share in the mission to radically change how healthcare is done. Headquartered in London, UK, Lifebit’s ecosystem of employees, partners, and customers spans 15 countries.
Lifebit press contact: pr@lifebit.ai
For more information on Lifebit and their commitment to genomic data security, visit lifebit.ai.